Company intelligence / Profile preview

Accelmed Partners II

Aventura, Florida, United States

Ownership: Private
Development stage: Other

Overview

Accelmed Partners II is the second private equity fund of Accelmed, focused on control and growth investments in U.S. commercial-stage HealthTech companies with revenues typically $20-70M. It closed at $400M hard cap in 2021, exceeding $300M target. Invests in medical devices, diagnostics, digital health, and tech-enabled services. Notable investments include Click Therapeutics, Acclaro Medical, GT Medical Technologies, Veranex, MedMinder. Predecessor fund Accelmed Partners I closed at $130M in 2016.

Industry: Investors

Beyond the preview

Go deeper on Accelmed Partners II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accelmed Partners II.

Explore the full profile